ClinicalTrials.Veeva

Menu

Goal Attainment Scaling in Upper Limb Spasticity Treatment (GASBTX)

U

University Rehabilitation Institute, Republic of Slovenia

Status

Enrolling

Conditions

Ischemic Stroke
Hemorrhagic Stroke

Treatments

Behavioral: Prescribed exercise program

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.

Full description

Goal setting will be performed by the patient together with the physician according to the SMART principle (specific, measureable, achievable, realistic, time bound). The goals will be classified according to the International Classification of Functioning, Disability and Health. Goal attainment will be assessed using the Goal Attainment Scale - Light. Comprehensive assessment of motor functioning will address range of motion, spasticity, pain, degree of motor disability and degree of dependence in daily activities. The prescribed exercises for the test group will be passive or active, depending on spasticity of the impaired upper limb. Both groups will keep an Exercise Diary during the second part of the study.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient's or caregiver's approval
  • ischemic or hemorrhagic stroke diagnosed using head CT/MRI
  • at least one upper limb muscle spasticity (MAS ≥ 3)
  • candidate for BTX-A treatment or already given BTX-A in the past
  • patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points)

Exclusion criteria

  • aphasic patients without caregiver's presence
  • other neurological or musculoskeletal diseases that could affect the treatment outcome

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Test group
Experimental group
Description:
Prescribed exercise program
Treatment:
Behavioral: Prescribed exercise program
Control group
No Intervention group
Description:
Exercising at patient's own discretion

Trial contacts and locations

1

Loading...

Central trial contact

Metka Moharić, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems